Latest News

CQRS coding issue at Microtest GP practices

CQRS coding issue at Microtest GP practices Kernow Local Medical Committee (LMC) has expressed its concern to Microtest on behalf of local GP practices about its coding for the Calculating Quality Reporting Service (CQRS) which counts towards Quality Outcomes Framework (QOF) payments. There have been reports that some local practices’ year-end figures weren’t as expected, due to a technical issue with the coding. Practices are understandably very concerned over the financial and workload impact. The LMC has sought assurances from Microtest that it is addressing the matter and will continue to monitor the issue and provide updates when there are new developments. Of the 32 local Microtest practices, 11 are now fully resolved, 19 are in progress and two have had no reported issues. If practices have concerns they can email Microtest’s helpdesk at: The LMC understands that Microtest and NHS Kernow will undertake a review to identify the cause of the issue, lessons learnt and recommendations to prevent a... read more

URGENT Levomepromazine 25mg/ml injection supply issue – information for Primary Care

URGENT Levomepromazine 25mg/ml injection supply issue – information for Primary Care   Overview of Supply Sanofi informed NHS England and DHSC on 5th April 2019 that they are going out of stock this week of levomepromazine 25mg/ml injection and new stock is expected to be available from the end of April. The supply issue is due to a quality deviation experienced at their Italian factory and is not linked to EU exit. The only other UK supplier, Wockhardt, have informed us that due to the unexpected increase in demand, they will also go out of stock of levomepromazine injection and their next delivery has been delayed with further stock expected at the end of April. Wockhardt have confirmed the remaining levomepromazine 25mg/mL injection stock which is held at Alliance will be ring-fenced for primary care use only. Stock at Alliance is limited and will not last until the end of April. Existing stocks are likely to be exhausted by end of this week and no new supplies are expected until end of April. GPs, palliative care networks and community pharmacies should consider the following advice and work together during this period to ensure patients can be managed appropriately.   Alternative agents UK Medicines Information with support of national clinical specialists have developed the following clinical information to help support the management of patients  who may be affected by this issue. Please follow the link to view this guidance: All the suppliers of the following medicines have  been made aware of this supply issue and have confirmed they can support an increase in demand should this be required. Haloperidol 5mg/1ml... read more